| A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors (NCT05136092) | Weill Medical College of Cornell University | 2022-02-16 |
| VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC) (NCT04166383) | National Cancer Institute (NCI) | 2020-08-09 |
| Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors (NCT05484687) | Affiliated Hospital of Nantong University | 2020-03-24 |
| A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment (NCT03428958) | NuCana plc | 2018-10-05 |
| An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread (NCT03377361) | Bristol-Myers Squibb | 2018-01-31 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 (NCT03050814) | National Cancer Institute (NCI) | 2017-04-05 |
| Predictive Factors for Anastomotic Leakage After Colorectal Surgery (NCT02347735) | Maastricht University Medical Center | 2015-08-01 |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) (NCT01671592) | Pawel Kalinski | 2013-01-01 |
| Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population (NCT01793207) | Cairo University | 2012-12-01 |
| Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer (NCT01545141) | Roswell Park Cancer Institute | 2012-10-01 |
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer (NCT01675128) | National Cancer Institute (NCI) | 2012-08-01 |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin (NCT01157039) | AHS Cancer Control Alberta | 2011-10-01 |
| Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome (NCT02399059) | Hospital General Universitario Elche | 2011-01-01 |
| Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (NCT01139138) | The Queen Elizabeth Hospital | 2010-06-01 |
| Dendritic Cell Vaccination for Patients with Solid Tumors (NCT01291420) | University Hospital, Antwerp | 2010-05-03 |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study (NCT00704600) | Maastricht Radiation Oncology | 2008-09-01 |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00478634) | Novartis Pharmaceuticals | 2007-05-01 |